Skip to Content

Arena Pharmaceuticals, Inc.

Company NameArena Pharmaceuticals, Inc.
Stock SymbolARNA

The Firm is investigating potential claims on behalf of investors of Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) (“Arena” or “the Company”) and whether the officers and directors complied with their legal obligations to the Company and its shareholders.

Arena announced on October 5, 2015, that, “at the request of the Board of Directors, Jack Lief, Arena's President and Chief Executive Officer, has retired from the company, including its Board of Directors.” The Company further disclosed that, “it is conducting an ongoing evaluation of its programs and operations, and intends to provide details regarding its 2016 financial plan later this year.” GPM’s investigation focuses on whether the Company and its directors have breached any fiduciary duties owed to shareholders, or otherwise committed corporate waste and/or permitted a lack of adequate internal controls with respect to the announcement on October 5, 2015.

If you own Arena shares, if you have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224 or by email to

Submit Your Information

If you suffered a loss on your Arena Pharmaceuticals, Inc. investments or would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below.

An attorney will contact you at no cost to provide you information about joining the action and answer your questions. Please note that submission of this form does not by itself form an attorney-client relationship nor does filing out this form mean you have joined any lawsuit.

Shares Purchased

Number of SharesBuy DatePrice Per ShareAdd

Shares Sold

Number of SharesSell DatePrice Per ShareAdd